| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chryssikopoulos A et al. | Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception. | 1997 | Gynecol. Endocrinol. | pmid:9174853 |
| Saxena BN et al. | Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration. | 1977 | J. Steroid Biochem. | pmid:916668 |
| Greyling MD et al. | Ligand specificity of uterine oestrogen and progesterone receptors in the subadult African elephant, Loxodonta africana. | 1997 | J. Reprod. Fertil. | pmid:9155728 |
| Hanson RM and Melzer DJ | Estrogen replacement therapy: new options, continuing concerns. | 1997 | JAMA | pmid:9153359 |
| Seeking new methods. | 1977 | People | pmid:913851 | |
| Schwingl PJ and Shelton J | Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. | 1997 | Contraception | pmid:9114999 |
| Mueck AO et al. | Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. | 1997 | Horm. Metab. Res. | pmid:9105905 |
| Tilly-Kiesi M et al. | Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. | 1997 | Atherosclerosis | pmid:9105568 |
| Patton DL et al. | Oral contraceptives do not alter the course of experimentally induced chlamydial salpingitis in monkeys. | 1994 Mar-Apr | Sex Transm Dis | pmid:9071418 |
| Rosenfeld WE et al. | Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. | 1997 | Epilepsia | pmid:9070594 |
| Coulter A and Sheldon T | The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. | 1997 | Br J Obstet Gynaecol | pmid:9070157 |
| McCune GS | The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. | 1997 | Br J Obstet Gynaecol | pmid:9070156 |
| Ditkoff EC et al. | The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation. | 1997 | J. Assist. Reprod. Genet. | pmid:9048239 |
| Bozhinova S | [The use of the Norcolut preparation in gynecologic; practice]. | 1996 | Akush Ginekol (Sofiia) | pmid:9045566 |
| Klaiber EL et al. | Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. | 1996 | Psychoneuroendocrinology | pmid:9044441 |
| Helle SI et al. | Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. | 1996 | Clin. Endocrinol. (Oxf) | pmid:9039339 |
| Nathorst-Böös J and Hammar M | Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. | 1997 | Maturitas | pmid:9032742 |
| Smith AM | Choice of oestrogen/progestagen regimen, for symptoms of the climacteric. | 1979 | Lancet | pmid:90284 |
| White IN and Muller-Eberhard U | Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. | 1977 | Biochem. J. | pmid:901418 |
| Nenseter MS et al. | Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. | 1996 | Eur. J. Clin. Invest. | pmid:9013080 |
| Singh M et al. | Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women. | 1997 | Contraception | pmid:9013058 |
| Schmit A et al. | Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. | 1996 | Dig. Dis. Sci. | pmid:9011441 |
| Perry HD and Mallen FJ | Cilioretinal artery occlusion associated with oral contraceptives. | 1977 | Am. J. Ophthalmol. | pmid:900218 |
| Voigt R et al. | [Clinical studies on the effect of long term progestagen administration on the elimination of noramidopyrine methanesulfonate (Analgin)]. | 1977 | Zentralbl Gynakol | pmid:899364 |
| Viinikka L et al. | Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2. | 1997 | Obstet Gynecol | pmid:8990448 |
| Wonodirekso S et al. | Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. | 1996 | Hum. Reprod. | pmid:8982756 |
| Kovacs G | Progestogen-only pills and bleeding disturbances. | 1996 | Hum. Reprod. | pmid:8982741 |
| Mueck AO et al. | Urinary cGMP excretion after hormone replacement therapy in postmenopausal women. | 1996 | Exp. Clin. Endocrinol. Diabetes | pmid:8957275 |
| Couzinet B et al. | The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. | 1996 | J. Clin. Endocrinol. Metab. | pmid:8954018 |
| Serup J et al. | Natural oestrogens for oral contraception. | 1979 | Lancet | pmid:89531 |
| Thom MH et al. | Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. | 1979 | Lancet | pmid:89511 |
| Imthurn B et al. | Effect of a programmed short-term stimulation protocol on the replacement of cryopreserved embryos. | 1996 | J. Assist. Reprod. Genet. | pmid:8947818 |
| Raymond EG et al. | Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants. | 1996 | Fertil. Steril. | pmid:8941061 |
| Pommier F et al. | Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. | 1996 | J Chromatogr A | pmid:8938383 |
| Wu JY | Collaborative study of an assay for progestational steroids in individual contraceptive tablets. | 1977 | J Assoc Off Anal Chem | pmid:893310 |
| Oon CJ et al. | Hepatocellular carcinoma in a patient on oral contraception who had been exposed to hepatitis B virus. | 1979 | Lancet | pmid:89298 |
| Eiken P et al. | Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. | 1996 | Bone | pmid:8922661 |
| Cédrin-Durnerin I et al. | The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. | 1996 | Hum. Reprod. | pmid:8921054 |
| Hermans C et al. | More on gastric antral vascular ectasia (watermelon stomach) in uremic patients. | 1996 Sep-Oct | Perit Dial Int | pmid:8914187 |
| Dören M and Schneider HP | Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. | 1996 | Maturitas | pmid:8905600 |
| Howard G et al. | The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X. | 1977 | Br J Obstet Gynaecol | pmid:889752 |
| Speroff L et al. | The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. | 1996 | JAMA | pmid:8892714 |
| Istre O et al. | Hormone replacement therapy after transcervical resection of the endometrium. | 1996 | Obstet Gynecol | pmid:8885910 |
| Hill PV | Tubal pregnancy despite oral contraception. | 1977 | S. Afr. Med. J. | pmid:888044 |
| Farish E et al. | Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. | 1996 | Atherosclerosis | pmid:8879436 |
| Stadberg E et al. | 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. | 1996 | Maturitas | pmid:8861084 |
| Taskinen MR et al. | Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. | 1996 | Arterioscler. Thromb. Vasc. Biol. | pmid:8857916 |
| Friedrich E | [The effect of low dose gestagens on the hypothalamic-pituitary-ovarian axis]. | 1977 | Fortschr. Med. | pmid:885464 |
| Pasapera AM et al. | In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents. | 1995 | Arch. Med. Res. | pmid:8845651 |
| Görög S et al. | Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices. | 1995 | J Pharm Biomed Anal | pmid:8833970 |